Dilapan-S®: A Multicenter US E-registry

Dilapan-S®: A Multicenter US E-registry
Conditions:   Post Term Pregnancy;   Premature Rupture of Membrane;   Fetal Growth Retardation;   Oligohydramnios;   Gestational Diabetes;   High Blood Pressure in Pregnancy
Intervention:   Device: Dilapan-S
Sponsors:   Medicem Technology s.r.o.;   The University of Texas Medical Branch, Galveston
Enrolling by invitation

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 22, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine